About this trial
This study will evaluate the efficacy of a structured parent-mediated behavioral intervention called Sleep Parent Treatment (SPT) for insomnia in autistic children ages 3 to 7 years 11 months, compared to another behavioral intervention called Sleep Parent Education (SPE). Eligible children will be randomly assigned to either the SPT or SPE intervention for 10 weeks.
Eligibility criteria
Qualifiers
Age >3 to 7 years 11 months
Clinical diagnosis of ASD supported by the Autism Diagnostic Interview Revised (ADI-R)
Score of 30 or more on the Parent-Rated Insomnia Scale - ASD (PAIRS) and the Clinical Global Impression Severity (CGI-S) score of Moderate or greater (a score of 4 or more)
Medication and supplement free or on stable medication or supplements (no changes in the past 6 weeks and no planned changes for 10 weeks of the randomized trial)
Disqualifiers
Children with a history of serious medical condition or known medical cause insomnia (e.g., nocturnal seizures, unresolved gastrointestinal problems such as reflux or constipation)
Children with a psychiatric disorder or serious behavioral problem requiring a different treatment
Children with known sleep apnea, restless leg syndrome, or periodic limb movements during sleep, or a circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome)
Children of non-English language speaking caregivers will be excluded because study intervention materials and many of the study measures are only available in English
Trial design
Treatments tested in this trial
- Sleep Parent Training (SPT)
- Sleep Parent Education (SPE)
Treatment groups
Sponsors and collaborators
Emory University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
The Cleveland Clinic
Collaborator
Ohio State University
Collaborator